NeuroFinance Human Stress Trial During Financial and Informational Volatility

Summary

The NeuroFinance Human Stress Trial (NFHST-2026-001) is a decentralized observational clinical study designed to evaluate how financial market volatility, economic uncertainty, digital media exposure, and information-driven stress environments affect human physiologic and behavioral health. Participants will undergo remote monitoring using wearable biosensors, cardiovascular telemetry devices, sleep tracking systems, heart rate variability monitoring, and behavioral analytics platforms. The study will use artificial intelligence and machine learning systems to analyze relationships between external financial and informational events and biologic stress responses, including autonomic nervous system activity, sleep disruption, cardiovascular strain, emotional resilience, and inflammatory signaling. The goal of the study is to develop predictive digital biomarkers and AI-assisted forecasting systems capable of identifying stress-related physiologic deterioration before clinical manifestation.

Conditions

• Psychological Stress
• Anxiety
• Emotional Stress
• Autonomic Nervous System Dysfunction
• Sleep Disturbance
• Insomnia
• Behavioral Health
• Cognitive Fatigue
• Occupational Stress
• Financial Stress
• Burnout Syndrome
• Heart Rate Variability
• Neurobehavioral Manifestations

Interventions

DEVICE

Wearable Physiologic Monitoring Platform

Commercially available wearable physiologic monitoring devices and digital health technologies will be used to collect continuous or intermittent biometric, cardiovascular, autonomic nervous system, behavioral, and sleep-related data during exposure to financial market volatility, economic uncertainty, and information-driven stress environments. Monitoring technologies may include: wearable ECG devices, heart rate variability (HRV) monitors, blood pressure monitoring systems, sleep tracking devices, galvanic skin response sensors, activity monitoring wearables, voice analysis systems, and optional EEG-enabled wearable technologies. Data generated from these systems will be integrated with artificial intelligence and machine learning-based analytics platforms for evaluation of physiologic stress responses and digital biomarker forecasting.

Sponsors & Collaborators

• Truway Health, Inc.

  lead INDUSTRY

Principal Investigators

• Gavin C Solomon, Investigator · Truway Health, Inc.

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2026-07-15

Primary Completion

2028-12-31

Completion

2029-06-30

FDA Device

Yes

Countries

• United States

Study Locations